Demand for Coagulation Testing Driving Global Blood Coagulation Analyzer Market
By LabMedica International staff writers Posted on 22 Jun 2019 |
Image: The global blood coagulation analyzer market is being driven by its increasing scope, product types and applications (Photo courtesy of openPR).
The global blood coagulation analyzer market is projected to grow at a substantial CAGR of 5.9% over the period 2018 to 2023, driven by its increasing scope, product types, and applications.
The demand for coagulation testing, increasing healthcare expenditure, rapid development of hospitals and primary healthcare centers, growing occurrences of lifestyle-related conditions such as diabetes, obesity, and cardiovascular disorders, and developing healthcare infrastructure are other factors aiding the market growth. However, the high cost of devices and presence of alternatives is likely to hamper the growth of the blood coagulation analyzer market.
These are the latest findings of Radiant Insights, Inc. (San Francisco, CA, USA), a market intelligence and consulting firm.
Geographically, North America accounted for the largest share of the global blood coagulation analyzer market in 2015 and will continue to lead the market during the forecast period. The North American market is being driven by increased awareness of blood-related diseases among its people, rising prevalence of CVD and growing usage of coagulation analyzers in the region. The key players contributing to the robust growth of the blood coagulation analyzers market are entering into partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Related Links:
Radiant Insights, Inc.
The demand for coagulation testing, increasing healthcare expenditure, rapid development of hospitals and primary healthcare centers, growing occurrences of lifestyle-related conditions such as diabetes, obesity, and cardiovascular disorders, and developing healthcare infrastructure are other factors aiding the market growth. However, the high cost of devices and presence of alternatives is likely to hamper the growth of the blood coagulation analyzer market.
These are the latest findings of Radiant Insights, Inc. (San Francisco, CA, USA), a market intelligence and consulting firm.
Geographically, North America accounted for the largest share of the global blood coagulation analyzer market in 2015 and will continue to lead the market during the forecast period. The North American market is being driven by increased awareness of blood-related diseases among its people, rising prevalence of CVD and growing usage of coagulation analyzers in the region. The key players contributing to the robust growth of the blood coagulation analyzers market are entering into partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Related Links:
Radiant Insights, Inc.
Latest Industry News
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus